BDNF and major depressive disorder: A recent systematic review carried out by our group summarized the roles of circulating levels of BDNF and BDNF-related polymorphisms (notably Val66Met) as biomarkers of treatment response in in patients with Major Depressive Disorder (MDD) [6].